Skip to main content
Clinical Trials/NCT03968510
NCT03968510
Completed
Not Applicable

The Effect of Parathyroidectomy on Swallowing Related Quality of Life in Primary Hyperparathyroidism

Uşak University1 site in 1 country150 target enrollmentNovember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperparathyroidism
Sponsor
Uşak University
Enrollment
150
Locations
1
Primary Endpoint
Change in quality of life
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Detailed Description

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Registry
clinicaltrials.gov
Start Date
November 1, 2018
End Date
November 1, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Uşak University
Responsible Party
Principal Investigator
Principal Investigator

Barış Sevinç

Assistant professor

Uşak University

Eligibility Criteria

Inclusion Criteria

  • no diagnosis of Alzheimers disease
  • must be able to swallow tablets Planned operation for primary hyperparathyroidism

Exclusion Criteria

  • secondary or tertiary hyperparathyroidism
  • insulin dependent diabetes
  • thyroid disease

Outcomes

Primary Outcomes

Change in quality of life

Time Frame: 6 months

Quality of life will be evaluated using short form 36

Study Sites (1)

Loading locations...

Similar Trials